Skip to main content
Log in

Synthesis, Some Transformations, and Biological Properties of 3-Phenethyl-2-Thioxo-2,3-Dihydro-1H-spiro[Benzo[H]Quinazoline-5,1′-Cycloheptane]-4(6H)-Ones

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The reaction of ethyl 4′-amino-1′H-spiro[cycloheptane-1, 2′-naphthalene]-3′-carboxylate with phenethylisothiocyanate followed by cyclization of the intermediate thiourea synthesized 3-phenethyl-2-thioxo-2,3-dihydro-1H-spiro[benzo[h]quinazoline-5,1′-cycloheptane]-4(6H)-one (2-thioxobenzo[h]quinazoline), which was alkylated in the presence of alkali into 2-alkylthio-substituted 3-phenethyl-3H-spiro[benzo[h]quinazoline-5,1′-cycloheptane]-4(6H)-ones. 2-Thioxobenzo[h]quinazoline was converted to 2-hydrazinyl-3-phenethyl-3H-spiro[benzo[h]quinazoline-5,1′-cycloheptane]-4(6H)-one, condensation of which with carbon disulfide resulted in 1-mercapto-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1′-cycloheptane]- 5(7H)-one. A study of the antitumor properties of the synthesized compounds showed that some of them were active (37 – 66%) against sarcoma 180. The synthesized compounds possessed weak bacteriostatic activity against Gram-positive (St. aureus 209 P and 1) and Gram-negative microorganisms (Sh. flexneri 6858 and E. coli 0 – 55).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. H. K. Maurya, M. Hasanain, S. Singh, et al., RSC Adv., 22(6), 18607 – 18618 (2016).

    Article  Google Scholar 

  2. L. Wu and Ch. Zhang, RSC Adv., 34(6), 28555 – 28562 (2016); doi https://doi.org/10.1039/C6RA03323G.

    Article  CAS  Google Scholar 

  3. A. K. Keshari, A. K. Singh, V. Raj, et al., Drug Des., Dev. Ther., 11, 1623 – 1642 (2017); doi https://doi.org/10.2147/DDDT.S136692.

    Article  CAS  Google Scholar 

  4. A. K. Keshari, A. K. Singh, U. Kumar, et al., Drug Des., Dev. Ther., 11, 2981 – 2995 (2017).

    Article  CAS  Google Scholar 

  5. L.Wu, Ch. Zhang, and W. Li, Bioorg. Med. Chem. Lett., 23(17), 5002 – 5005 (2013).

    Article  CAS  Google Scholar 

  6. H. Ohtomo, T. Tagata, K. Sasaki, et al., Tetrahedron, 63(51), 12541 – 12546 (2007).

    Article  CAS  Google Scholar 

  7. N. Sati, S. Kumar, and M. S. M. Rawat, Indian J. Pharm. Sci., 71(5), 572 – 575 (2009).

    Article  CAS  Google Scholar 

  8. Y. A. Mohamed, A. G. Amr, S. F. Mohamed, et al., J. Chem. Sci., 124(3), 693 – 702 (2012).

    Article  CAS  Google Scholar 

  9. M. Sahoo, L. Jena, S. Daf, et al., Genomics Inf., 14(3), 104 – 111 (2016); doi https://doi.org/10.5808/GI.2016.14.3.104.

    Article  Google Scholar 

  10. R. Gupta and R. P. Chaudhary, Phosphorus, Sulfur Silicon Relat. Elem., 187(6), 735 – 742 (2012).

    Article  CAS  Google Scholar 

  11. R. Gali, J. Banothu, M. Porika, et al., Bioorg. Med. Chem. Lett., 24(17), 4239 – 4242 (2014).

    Article  CAS  Google Scholar 

  12. S. M. Gomha, E. M. H. Abbas, and T. A. Farghaly, J. Heterocycl. Chem., 54, 610 – 617 (2017); doi: https://doi.org/10.1002/jhet.2632.

    Article  CAS  Google Scholar 

  13. M. Y. Ebied, W. A. Zaghary, K. M. Amin, et al., J. Adv. Pharm. Res., 1(4), 216 – 227 (2017); doi: https://doi.org/10.21608/aprh.2017.4043.

    Article  Google Scholar 

  14. C. Brullo, M. Rocca, P. Foss, et al., Bioorg. Med. Chem. Lett., 22(2), 1125 – 1129 (2012).

    Article  CAS  Google Scholar 

  15. H. K. Maurya, R. Vema, S. Alam, et al., Bioorg Med. Chem. Lett., 23(21), 5844 – 5849 (2013).

    Article  CAS  Google Scholar 

  16. A. I. Markosyan, Kh. S. Hakopyan, S. H. Gabrielyan, et al., Electron. J. Nat. Sci. NAS RA, 30(2), 39 – 42 (2018).

    Google Scholar 

  17. A. I. Markosyan, Kh. S. Hakopyan, A. S. Ayvazyan, et al., Chem. J. Arm., 71(4), 596 – 608 (2018).

    CAS  Google Scholar 

  18. A. I. Markosyan, A. S. Ayvazyan, S. A. Gabrielyan, et al., Khim.-farm. Zh., 54(5), 21 – 25 (2020); Pharm. Chem. J., 54(5), 449 – 454 (2020).

  19. A. I. Markosyan, A. S. Ayvazyan, S. H. Gabrielyan, et al., Electron. J. Nat. Sci. NAS RA, 34(1), 22 – 27 (2020).

    Google Scholar 

  20. A. I. Markosyan, S. V. Dilanyan, S. H. Gabrielyan, et al., Electronic J. Nat. Sci. NAS RA, 27(2), 23 – 27 (2016).

    Google Scholar 

  21. A. I. Markosyan, K. K. Airapetyan, S. A. Gabrielyan, et al., Zh. Org. Khim., 54(4), 604 – 611 (2018).

    Google Scholar 

  22. A. I. Markosyan, S. V. Dilanyan, R. S. Sukasyan, et al., Khim.- farm. Zh., 42(3), 16 – 19 (2008); doi https://doi.org/10.30906/0023-1134-2008-42-3-16-19.

    Article  Google Scholar 

  23. A. I. Markosyan, M. G. Oganisyan, R. A. Kuroyan, et al., Arm. Khim. Zh., 45(3–4), 208 – 211 (1992).

    Google Scholar 

  24. A. I. Markosyan, K. K. Airapetyan, S. A. Gabrielyan, et al., Khim. Zh. Arm., 71(3), 377 – 388 (2018).

    CAS  Google Scholar 

  25. A. I. Markosyan, A. S. Ayvazyan, S. H. Gabrielyan, et al., Chem. J. Arm., 72(4), 469 – 482 (2019).

    CAS  Google Scholar 

  26. A. I. Markosyan, A. S. Ayvazyan, S. H. Gabrielyan, et al., Khim.-farm. Zh., 55(2), 24 – 28 (2021); doi: 0.30906/0023-1134-2021-55-2-24-28; Pharm. Chem. J., 55(2), 133 – 137 (2020).

  27. A. I. Markosyan, A. S. Ayvazyan, S. A. Gabrielyan, et al., Zh. Org. Khim., 57(3), 410 – 419 (2021); doi: 10.31857/S0514749221030095.

  28. A. S. Ayvazyan, Khim. Zh. Arm., 74(1–2), 87 – 100 (2021).

    Google Scholar 

  29. A. S. Ayvazyan, Electron. J. Nat. Sci. NAS RA, 36(1), 26 – 30 (2021).

    Google Scholar 

  30. A. N. Mironov, Handbook for Preclinical Drug Studies [in Russian], Grif i K, Moscow (2012), pp. 509 – 524.

    Google Scholar 

  31. Z. P. Sof′ina, A. B. Syrkin, A. Goldin, et al., Experimental Assessment of Antitumor Drugs in the USSR and USA [in Russian], Meditsina, Moscow (1980).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. I. Markosyan.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 10, pp. 17 – 22, October, 2022.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markosyan, A.I., Ayvazyan, A.S., Gabrielyan, S.A. et al. Synthesis, Some Transformations, and Biological Properties of 3-Phenethyl-2-Thioxo-2,3-Dihydro-1H-spiro[Benzo[H]Quinazoline-5,1′-Cycloheptane]-4(6H)-Ones. Pharm Chem J 56, 1321–1326 (2023). https://doi.org/10.1007/s11094-023-02792-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-023-02792-6

Keywords

Navigation